Danmarks Nationalbank
7.1.2026 17:00:00 CET | Globenewswire | Press release
Opening of new 2-year Danish Government Bond on 21 January 2026
Opening of new 2-year Danish Government Bond on 21 January 2026
On 21 January 2026, the Kingdom of Denmark will issue a new DGB 2.00 per cent 2028 (ISIN: DK0009925265) via auction. Coupons will be paid annually on 15 November and maturity will be on 15 November 2028. The new bond will replace DGB 0.50 per cent 2027 as key on-the-run issue. After this the central government can conduct buy-backs in DGB 0.50 per cent 2027.
The sale will commence via MTS Denmark's auction system with primary dealers as counterparties. The opening is contingent on stable market conditions. At the auction, the total sale will not exceed DKK 6 billion at nominal value.
As from 8:00 a.m. (CET) on the opening day, bids can be submitted until 10:15 a.m. Subsequently, a cut-off price will be fixed as quickly as possible and within 10 minutes at the latest. Bids at the cut-off price or above will be accommodated at the cut-off price. A pro-rata allocation of bids at the cut-off price may be applied.
Terms of borrowing can be viewed on www.governmentdebt.dk under Terms of borrowing.
Securities lending
DGB 2.00 per cent 2028 will be included in the central government's securities lending facility from 21 January 2026.
Further information
For further information please contact the Danish debt management office at governmentdebt@nationalbanken.dk.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Shufti Pro Limited19.8.2026 16:00:00 CEST | Press release
Shufti Helps Obliged Entities Get Ready for the EU AMLR Ahead of the July 2027 Deadline
Cosmos Health Inc.19.8.2026 15:00:00 CEST | Press release
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
Teva Pharmaceutical Industries Ltd19.8.2026 14:30:00 CEST | Press release
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
Exclaimer Ltd.19.8.2026 14:00:00 CEST | Press release
Exclaimer Launches MSP Connect to Remove Billing and Management Friction for MSPs
Aduro Clean Technologies Inc.19.8.2026 14:00:00 CEST | Press release
Aduro Selects Saipem for Engineering and Procurement Support for First-of-a-Kind HCT Facility at Chemelot
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom